Safety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous Nephropathy
Clinical trial NCT07266181 · RECRUITING
Trial details
- NCT number
- NCT07266181
- Sponsor
- The First Affiliated Hospital of Air Force Medicial University
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-08
- Primary completion
- 2027-07-31
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.